Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Avenue Therapeutics Inc (ATXI)

Avenue Therapeutics Inc (ATXI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Avenue Therapeutics Inc 1111 Kane Concourse Suite 301 Bay Harbor Islands FL 33154 USA

www.avenuetx.com Employees: 2 P: 781-652-4500

Sector:

Medical

INDUSTRY GROUPING:

Medical - Drugs

Description:

Avenue Therapeutics, Inc. is a specialty pharmaceutical company. It acquires, licenses, develops and commercializes products principally for use in the acute/intensive care hospital setting. Avenue Therapeutics, Inc. is based in New York, United States.

Key Statistics

Overview:

Market Capitalization, $K 2,421
Enterprise Value, $K -169
Shares Outstanding, K 3,183
Annual Sales, $ 0 K
Annual Net Income, $ -11,650 K
Last Quarter Sales, $ 1,400 K
Last Quarter Net Income, $ 340 K
EBIT, $ -6,370 K
EBITDA, $ -6,370 K
60-Month Beta -0.33
% of Insider Shareholders 1.80%
% of Institutional Shareholders 17.34%
Float, K 3,126
% Float 98.20%
Short Volume Ratio 0.05

Growth:

1-Year Return -57.44%
3-Year Return -99.27%
5-Year Return -99.98%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 99.15%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.21 on 11/13/25
Next Earnings Date N/A
Earnings Per Share ttm -0.95
EPS Growth vs. Prev Qtr -290.91%
EPS Growth vs. Prev Year 89.06%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-75 on 04/26/24

ATXI Ratios

Ratio
Price/Earnings ttm 1.18
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 217.35%
Return-on-Assets % 143.19%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales 1.73
Price/Cash Flow N/A
Price/Book 1.24
Book Value/Share 0.89
Interest Coverage -1.52
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar